Halozyme Therapeutics, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/16/2026 | 2,187 | 0.0% | 32,500 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 2,391 | 0.0% | 32,600 | 9/30/2025 |
| 2025 Q2 | 7/23/2025 | 1,805 | 0.0% | 34,700 | 6/30/2025 |
| 2025 Q1 | 5/1/2025 | 2,272 | 0.0% | 35,600 | 3/31/2025 |
| 2024 Q4 | 1/29/2025 | 1,688 | 0.0% | 35,300 | 12/31/2024 |
| 2024 Q3 | 10/23/2024 | 2,009 | 0.0% | 35,100 | 9/30/2024 |
| 2024 Q2 | 7/24/2024 | 1,885 | 0.0% | 36,000 | 6/30/2024 |
| 2024 Q1 | 4/23/2024 | 1,546 | 0.0% | 38,000 | 3/31/2024 |
| 2023 Q4 | 1/29/2024 | 1,371 | 0.0% | 37,100 | 12/31/2023 |
| 2023 Q3 | 10/17/2023 | 1,429 | 0.0% | 37,400 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 1,389 | 0.0% | 38,500 | 6/30/2023 |
| 2023 Q1 | 4/19/2023 | 1,371 | 0.0% | 35,900 | 3/31/2023 |
| 2022 Q4 | 1/24/2023 | 2,060 | 0.1% | 36,200 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 1,451 | 0.0% | 36,700 | 9/30/2022 |
| 2022 Q2 | 7/20/2022 | 1,812 | 0.0% | 36,200 | 6/30/2022 |
| 2022 Q1 | 4/22/2022 | 1,598 | 0.0% | 36,900 | 3/31/2022 |
| 2021 Q4 | 1/14/2022 | 1,456 | 0.0% | 36,200 | 12/31/2021 |
| 2021 Q3 | 10/12/2021 | 1,477 | 0.0% | 36,300 | 9/30/2021 |
| 2021 Q2 | 7/16/2021 | 1,576 | 0.0% | 34,700 | 6/30/2021 |
| 2021 Q1 | 4/14/2021 | 1,376 | 0.0% | 33,000 | 3/31/2021 |
| 2020 Q4 | 1/11/2021 | 1,358 | 0.0% | 31,800 | 12/31/2020 |